Search research articles
Contact Us
Filters
Showing results (411-420 of 432) with videos related to
Page
of 44
Sort By:
Scandinavian Journal of Urology
|
April 13, 2017
Prognostic and discriminative power of the 7th TNM classification for patients with surgically treated papillary renal cell carcinoma: results of a multi-institutional validation study (CORONA subtype project)
Matthias May, Cristian Surcel, Umberto Capitanio, et al.
Nature Communications
|
February 4, 2023
Mystery of fatal 'staggering disease' unravelled: novel rustrela virus causes severe meningoencephalomyelitis in domestic cats
Kaspar Matiasek, Florian Pfaff, Herbert Weissenböck, et al.
Urologic Oncology
|
July 5, 2023
BTA stat®, NMP22® BladderChek®, UBC® Rapid Test, and CancerCheck® UBC® rapid VISUAL as urinary marker for bladder cancer: Final results of a German multicenter study
Thorsten H Ecke, Christina J Meisl, Thorsten Schlomm, et al.
Genes, Chromosomes & Cancer
|
September 26, 2024
17p13 (TP53) Deletions Are Associated With an Aggressive Phenotype but Unrelated to Patient Prognosis in Urothelial Bladder Carcinomas
Martina Kluth, Melanie Hitzschke, Kira Furlano, et al.
BMC Cancer
|
April 14, 2025
Loss of chromosome Y is unrelated to the composition of the tumor microenvironment and patient prognosis in muscle-invasive urothelial bladder cancers
Henning Plage, Viktoria Ahlburg, Sebastian Hofbauer, et al.
Urology
|
December 3, 2024
Performance of Urinary Markers in Patients With Suspicious Cystoscopy During Follow-up of Recurrent Non-muscle Invasive Bladder Cancer: BTA Stat, NMP22 BladderChek, UBC Rapid Test, CancerCheck UBC Rapid VISUAL, and Uromonitor in Comparison to Cytology
Thorsten H Ecke, Christina J Meisl, Thorsten Schlomm, et al.
BJUI Compass
|
November 14, 2024
Reduced p63 expression is linked to unfavourable prognosis in muscle-invasive urothelial carcinoma of the bladder
Kira Furlano, Henning Plage, Sebastian Hofbauer, et al.
BMC Urology
|
April 24, 2024
PD-L1 expression in tumor and inflammatory cells is associated with favorable tumor features and favorable prognosis in muscle-invasive urothelial carcinoma of the bladder not treated by immune checkpoint inhibitors
Henning Plage, Kira Furlano, Sebastian Hofbauer, et al.
The Journal of Pathology. Clinical Research
|
December 13, 2024
Loss of MTAP expression is strongly linked to homozygous 9p21 deletion, unfavorable tumor phenotype, and noninflamed microenvironment in urothelial bladder cancer
Natalia Gorbokon, Niklas Wößner, Viktoria Ahlburg, et al.
World Journal of Urology
|
August 25, 2017
Prognostic significance of Fuhrman grade and age for cancer-specific and overall survival in patients with papillary renal cell carcinoma: results of an international multi-institutional study on 2189 patients
H Borgmann, M Musquera, A Haferkamp, et al.
Page
of 44
Search research articles
Search
Showing results (411-420 of 432) with videos related to
Sort By:
Page
of 44
Scandinavian Journal of Urology
|
April 13, 2017
Prognostic and discriminative power of the 7th TNM classification for patients with surgically treated papillary renal cell carcinoma: results of a multi-institutional validation study (CORONA subtype project)
Matthias May, Cristian Surcel, Umberto Capitanio, et al.
Nature Communications
|
February 4, 2023
Mystery of fatal 'staggering disease' unravelled: novel rustrela virus causes severe meningoencephalomyelitis in domestic cats
Kaspar Matiasek, Florian Pfaff, Herbert Weissenböck, et al.
Urologic Oncology
|
July 5, 2023
BTA stat®, NMP22® BladderChek®, UBC® Rapid Test, and CancerCheck® UBC® rapid VISUAL as urinary marker for bladder cancer: Final results of a German multicenter study
Thorsten H Ecke, Christina J Meisl, Thorsten Schlomm, et al.
Genes, Chromosomes & Cancer
|
September 26, 2024
17p13 (TP53) Deletions Are Associated With an Aggressive Phenotype but Unrelated to Patient Prognosis in Urothelial Bladder Carcinomas
Martina Kluth, Melanie Hitzschke, Kira Furlano, et al.
BMC Cancer
|
April 14, 2025
Loss of chromosome Y is unrelated to the composition of the tumor microenvironment and patient prognosis in muscle-invasive urothelial bladder cancers
Henning Plage, Viktoria Ahlburg, Sebastian Hofbauer, et al.
Urology
|
December 3, 2024
Performance of Urinary Markers in Patients With Suspicious Cystoscopy During Follow-up of Recurrent Non-muscle Invasive Bladder Cancer: BTA Stat, NMP22 BladderChek, UBC Rapid Test, CancerCheck UBC Rapid VISUAL, and Uromonitor in Comparison to Cytology
Thorsten H Ecke, Christina J Meisl, Thorsten Schlomm, et al.
BJUI Compass
|
November 14, 2024
Reduced p63 expression is linked to unfavourable prognosis in muscle-invasive urothelial carcinoma of the bladder
Kira Furlano, Henning Plage, Sebastian Hofbauer, et al.
BMC Urology
|
April 24, 2024
PD-L1 expression in tumor and inflammatory cells is associated with favorable tumor features and favorable prognosis in muscle-invasive urothelial carcinoma of the bladder not treated by immune checkpoint inhibitors
Henning Plage, Kira Furlano, Sebastian Hofbauer, et al.
The Journal of Pathology. Clinical Research
|
December 13, 2024
Loss of MTAP expression is strongly linked to homozygous 9p21 deletion, unfavorable tumor phenotype, and noninflamed microenvironment in urothelial bladder cancer
Natalia Gorbokon, Niklas Wößner, Viktoria Ahlburg, et al.
World Journal of Urology
|
August 25, 2017
Prognostic significance of Fuhrman grade and age for cancer-specific and overall survival in patients with papillary renal cell carcinoma: results of an international multi-institutional study on 2189 patients
H Borgmann, M Musquera, A Haferkamp, et al.
Page
of 44